238 related articles for article (PubMed ID: 36270281)
1. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
[TBL] [Abstract][Full Text] [Related]
2. Roadmap of the Early Events of
Guallar D
Cell Reprogram; 2023 Feb; 25(1):7-8. PubMed ID: 36695734
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.
Mah N; Wang Y; Liao MC; Prigione A; Jozefczuk J; Lichtner B; Wolfrum K; Haltmeier M; Flöttmann M; Schaefer M; Hahn A; Mrowka R; Klipp E; Andrade-Navarro MA; Adjaye J
PLoS One; 2011; 6(8):e24351. PubMed ID: 21909390
[TBL] [Abstract][Full Text] [Related]
4. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
Senís E; Mosteiro L; Grimm D; Abad M
Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells act as an extrinsic barrier for in vivo reprogramming.
Melendez E; Chondronasiou D; Mosteiro L; Martínez de Villarreal J; Fernández-Alfara M; Lynch CJ; Grimm D; Real FX; Alcamí J; Climent N; Pietrocola F; Serrano M
Development; 2022 Apr; 149(8):. PubMed ID: 35420133
[TBL] [Abstract][Full Text] [Related]
6. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing Between Endodermal and Pluripotent Stem Cell Lines During Somatic Cell Reprogramming.
Moauro A; Ralston A
Methods Mol Biol; 2022; 2429():41-55. PubMed ID: 35507154
[TBL] [Abstract][Full Text] [Related]
8. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
9. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.
Soufi A; Donahue G; Zaret KS
Cell; 2012 Nov; 151(5):994-1004. PubMed ID: 23159369
[TBL] [Abstract][Full Text] [Related]
10. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
[TBL] [Abstract][Full Text] [Related]
11. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
12. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.
Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T
Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202
[TBL] [Abstract][Full Text] [Related]
13. Comparison of reprogramming factor targets reveals both species-specific and conserved mechanisms in early iPSC reprogramming.
Fu K; Chronis C; Soufi A; Bonora G; Edwards M; Smale ST; Zaret KS; Plath K; Pellegrini M
BMC Genomics; 2018 Dec; 19(1):956. PubMed ID: 30577748
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
[TBL] [Abstract][Full Text] [Related]
15. Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells.
Ghazizadeh Z; Rassouli H; Fonoudi H; Alikhani M; Talkhabi M; Darbandi-Azar A; Chen S; Baharvand H; Aghdami N; Salekdeh GH
Mol Biotechnol; 2017 Jun; 59(6):207-220. PubMed ID: 28509990
[TBL] [Abstract][Full Text] [Related]
16. CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.
Lee SJ; Kang KW; Kim JH; Lee BH; Jung JH; Park Y; Hong SC; Kim BS
Stem Cells Dev; 2020 Feb; 29(3):119-132. PubMed ID: 31808362
[TBL] [Abstract][Full Text] [Related]
17. Biological importance of OCT transcription factors in reprogramming and development.
Kim KP; Han DW; Kim J; Schöler HR
Exp Mol Med; 2021 Jun; 53(6):1018-1028. PubMed ID: 34117345
[TBL] [Abstract][Full Text] [Related]
18. Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.
Soufi A; Zaret KS
Cell Cycle; 2013 May; 12(10):1487-91. PubMed ID: 23603987
[TBL] [Abstract][Full Text] [Related]
19. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
20. Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation.
Huynh LM; Shinagawa T; Ishii S
Stem Cells Dev; 2016 Feb; 25(3):251-8. PubMed ID: 26649967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]